1h Free Analyst Time
The cannabinoids market is forecasted to grow by USD 88.4 billion during 2023-2028, accelerating at a CAGR of 30.41% during the forecast period. The report on the cannabinoids market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by legalization of medicinal cannabinoids, advent of advanced cultivation processes for cannabinoids, and plans to increase production and availability of medical cannabinoids by governments.
The cannabinoids market is segmented as below:
By Application
- Medical
- Non-medical
By Channel
- Retail pharmacies
- Online stores
- Hospital
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the cannabinoids market covers the following areas:
- Cannabinoids market sizing
- Cannabinoids market forecast
- Cannabinoids market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global cannabinoids market: Aurora Cannabis Inc., Canopy Growth Corp., Cresco Labs LLC, Cronos Group Inc., CV Sciences Inc., Delta 9 Cannabis, Ecofibre Ltd., INDIVA.com LLC., Jazz Pharmaceuticals Plc, Medical Marijuana Inc., MediPharm Labs Inc., Medix CBD, Medterra CBD, MM Enterprises USA LLC, Organigram Holdings Inc., STENOCARE AS, Terrascend Canada, Tilray Brands Inc., Trulieve Cannabis Corp., and Unrivaled Brands Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is launch of medical cannabinoids education programs."
According to the report, one of the major drivers for this market is the legalization of medicinal cannabinoids.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aurora Cannabis Inc.
- Canopy Growth Corp.
- Cresco Labs LLC
- Cronos Group Inc.
- CV Sciences Inc.
- Delta 9 Cannabis
- Ecofibre Ltd.
- INDIVA.com LLC.
- Jazz Pharmaceuticals Plc
- Medical Marijuana Inc.
- MediPharm Labs Inc.
- Medix CBD
- Medterra CBD
- MM Enterprises USA LLC
- Organigram Holdings Inc.
- STENOCARE AS
- Terrascend Canada
- Tilray Brands Inc.
- Trulieve Cannabis Corp.
- Unrivaled Brands Inc.
